What combines best with GLP-1 for obesity treatment: GIP receptor agonists or antagonists?
Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning
Dokumenter
- What combines best with GLP-1 for obesity treatment: GIP receptor agonists or antagonists?
Forlagets udgivne version, 183 KB, PDF-dokument
Lu et al.1 previously demonstrated that antagonist antibodies against the GIP receptor promote weight loss combined with GLP-1. They now elegantly developed a conjugate of GIPR antibodies and GLP-1 and show effective weight loss in obese non-human primates.
Originalsprog | Engelsk |
---|---|
Artikelnummer | 100284 |
Tidsskrift | Cell Reports Medicine |
Vol/bind | 2 |
Udgave nummer | 5 |
Antal sider | 2 |
DOI |
|
Status | Udgivet - 2021 |
Antal downloads er baseret på statistik fra Google Scholar og www.ku.dk
Ingen data tilgængelig
ID: 272176361